Innovative approximate analytical solution for standard model of viral dynamics: hepatitis C with direct-acting agents as an implemented case

DOI10.1155/2019/1454739zbMath1435.92034OpenAlexW2973039712MaRDI QIDQ2298065

Yasmine Abouelseoud, Nermeen N. Ibrahim, Hesham A. Elkaranshawy, Hossam M. Ezzat

Publication date: 20 February 2020

Published in: Mathematical Problems in Engineering (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1155/2019/1454739

Mathematics Subject Classification ID

Epidemiology (92D30) Medical applications (general) (92C50) Analytical theory of ordinary differential equations: series, transformations, transforms, operational calculus, etc. (34A25) Medical epidemiology (92C60)

Related Items (3)

Parameter estimation and sensitivity analysis for a model of tumor-immune interaction in the presence of immunotherapy and chemotherapy ⋮ Mathematical modelling for the role of CD\(4^+\)T cells in tumor-immune interactions ⋮ Effect of DAA therapy in hepatitis C treatment -- an impulsive control approach

Cites Work

• Unnamed Item
• Unnamed Item
• The dynamics of HPV infection and cervical cancer cells
• Series solution of a nonlinear ODE arising in magnetohydrodynamic by HPM-Padé technique
• Hybrid Taguchi-differential evolution algorithm for parameter estimation of differential equation models with application to HIV dynamics
• Multiobjective optimal control of HIV dynamics
• Mathematical analysis of a basic virus infection model with application to HBV infection
• Global dynamics of a virus-immune system with virus-guided therapy and saturation growth of virus
• Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics
• Mathematical analysis of multiscale models for hepatitis C virus dynamics under therapy with direct-acting antiviral agents

This page was built for publication: Innovative approximate analytical solution for standard model of viral dynamics: hepatitis C with direct-acting agents as an implemented case